Dates: January 18-19, 2013; January 25-26, 2013; February 1-2, 2013
Location: Multiple locations
Sponsoring Group: The American Society of Hematology
Web Page URL: www.hematology.org/calendar_HOANA
Topics Covered: Myelodysplastic Syndromes Acute Myeloid Leukemia Myeloproliferative Neoplasms including Chronic Myeloid Leukemia Hematopoietic Stem Cell Transplantation Non-Hodgkin Lymphoma Disorders of Hemostasis Thrombosis and Anticoagulation Thrombotic Thrombocytopenic Purpura (TTP)/Hemolytic Uremic Syndrome (HUS) and Atypical HUS Novel Treatments for Relapsed/Refractory Chronic Immune Thrombocytopenia Bone Marrow Failure Chronic Lymphocytic Leukemia Plasma Cell Disorders (Myeloma)
Objectives: The eighth official Highlights of ASH will feature leading hematology experts who will present unbiased analysis of the 54th ASH Annual Meeting abstracts and sessions,including evolving therapies, the latest treatment options, and their clinical applications.
Continuing Education: Yes
Dec 11, 2013 - Many patients with myeloproliferative neoplasms without mutations in the Janus kinase 2 gene (JAK2) or in the thrombopoietin receptor gene (MPL) have mutations in the CALR gene encoding calreticulin, according to two studies published online Dec. 10 in the New England Journal of Medicine. The research was published to coincide with presentation at the annual meeting of the American Society of Hematology, held from Dec. 7 to 10 in New Orleans.
Dec 14, 2011
Aug 1, 2014